| p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis D Bergamaschi, M Gasco, L Hiller, A Sullivan, N Syed, G Trigiante, I Yulug, ... Cancer cell 3 (4), 387-402, 2003 | 553 | 2003 |
| Clinical update on head and neck cancer: molecular biology and ongoing challenges E Alsahafi, K Begg, I Amelio, N Raulf, P Lucarelli, T Sauter, M Tavassoli Cell death & disease 10 (8), 540, 2019 | 483 | 2019 |
| The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer S Kapitanovic, S Radosevic, M Kapitanovic, S Andelinovic, Z Ferencic, ... Gastroenterology 112 (4), 1103-1113, 1997 | 305 | 1997 |
| Clinical update on cancer: molecular oncology of head and neck cancer Y Suh, I Amelio, T Guerrero Urbano, M Tavassoli Cell death & disease 5 (1), e1018-e1018, 2014 | 255 | 2014 |
| Molecular markers in oral epithelial dysplasia G Pitiyage, WM Tilakaratne, M Tavassoli, S Warnakulasuriya Journal of oral pathology & medicine 38 (10), 737-752, 2009 | 233 | 2009 |
| TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells L Guelen, H Paterson, J Gäken, M Meyers, F Farzaneh, M Tavassoli Oncogene 23 (5), 1153-1165, 2004 | 203 | 2004 |
| p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells C Hooper, E Meimaridou, M Tavassoli, G Melino, S Lovestone, R Killick Neuroscience letters 418 (1), 34-37, 2007 | 195 | 2007 |
| The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma C Trivedy, K Warnakulasuriya, VK Hazarey, M Tavassoli, P Sommer, ... Journal of oral pathology & medicine 28 (6), 246-251, 1999 | 173 | 1999 |
| Epigenetic inactivation of 14-3-3 σ in oral carcinoma: association with p16INK4a silencing and human papillomavirus negativity M Gasco, AK Bell, V Heath, A Sullivan, P Smith, L Hiller, I Yulug, ... Cancer research 62 (7), 2072-2076, 2002 | 149 | 2002 |
| Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines M Sartor, H Steingrimsdottir, F Elamin, J Gäken, S Warnakulasuriya, ... British journal of cancer 80 (1), 79-86, 1999 | 132 | 1999 |
| E1A activates transcription of p73 and Noxa to induce apoptosis M Flinterman, L Guelen, S Ezzati-Nik, R Killick, G Melino, K Tominaga, ... Journal of Biological Chemistry 280 (7), 5945-5959, 2005 | 125 | 2005 |
| Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients S Warnakulasuriya, T Soussi, R Maher, N Johnson, M Tavassoli The Journal of pathology 192 (1), 52-57, 2000 | 112 | 2000 |
| Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in UK subjects: a novel method of detection F Elamin, H Steingrimsdottir, S Wanakulasuriya, N Johnson, M Tavassoli Oral oncology 34 (3), 191-197, 1998 | 108 | 1998 |
| MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance YE Suh, N Raulf, J Gäken, K Lawler, TG Urbano, J Bullenkamp, S Gobeil, ... International journal of cancer 137 (5), 1021-1034, 2015 | 106 | 2015 |
| MicroRNA‐196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance YE Suh, N Raulf, J Gäken, K Lawler, TG Urbano, J Bullenkamp, S Gobeil, ... International journal of cancer 137 (5), 1021-1034, 2015 | 106 | 2015 |
| Hereditary and environmental risk factors; clinical and laboratory risk markers for head and neck, especially oral, cancer and precancer NW Johnson, S Warnakulasuriy, M Tavassoli European journal of cancer prevention 5 (1), 5-17, 1996 | 98 | 1996 |
| c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma M Tavassoli, P Quirke, F Farzaneh, NJ Lock, LV Mayne, N Kirkham British journal of cancer 60 (4), 505-510, 1989 | 92 | 1989 |
| DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas CL Wu, L Roz, S McKown, P Sloan, AP Read, S Holland, S Porter, ... Genes, Chromosomes and Cancer 25 (1), 16-25, 1999 | 89 | 1999 |
| Delivery of therapeutic proteins as secretable TAT fusion products M Flinterman, F Farzaneh, N Habib, F Malik, J Gäken, M Tavassoli Molecular Therapy 17 (2), 334-342, 2009 | 81 | 2009 |
| p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity M Tavassoli, N Brunel, R Maher, NW Johnson, T Soussi International journal of cancer 78 (3), 390-391, 1998 | 81 | 1998 |
